Immunocore Holdings plc
IMCR
$28.14
-$0.38-1.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 106.68M | 104.48M | 103.69M | 97.96M | 93.88M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 106.68M | 104.48M | 103.69M | 97.96M | 93.88M |
| Cost of Revenue | 434.00K | -184.57M | 71.09M | 70.05M | 831.00K |
| Gross Profit | 106.24M | 289.05M | 32.61M | 27.92M | 93.05M |
| SG&A Expenses | 37.85M | 42.65M | 39.78M | 42.79M | 40.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -19.73M | -- | -- | -- |
| Total Operating Expenses | 99.40M | 104.44M | 110.86M | 112.84M | 97.50M |
| Operating Income | 7.28M | 37.00K | -7.17M | -14.88M | -3.62M |
| Income Before Tax | 13.27M | -15.79M | 304.00K | -9.69M | 6.08M |
| Income Tax Expenses | 301.00K | 14.27M | 481.00K | 606.00K | 1.06M |
| Earnings from Continuing Operations | 12.97M | -30.06M | -177.00K | -10.30M | 5.02M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.97M | -30.06M | -177.00K | -10.30M | 5.02M |
| EBIT | 7.28M | 37.00K | -7.17M | -14.88M | -3.62M |
| EBITDA | 8.23M | 871.00K | -6.37M | -14.10M | -2.76M |
| EPS Basic | 0.26 | -0.60 | 0.00 | -0.20 | 0.10 |
| Normalized Basic EPS | 0.14 | -0.20 | 0.00 | -0.12 | 0.01 |
| EPS Diluted | 0.25 | -0.60 | 0.00 | -0.20 | 0.10 |
| Normalized Diluted EPS | 0.14 | -0.20 | 0.00 | -0.12 | 0.01 |
| Average Basic Shares Outstanding | 50.75M | 50.47M | 50.40M | 50.29M | 50.09M |
| Average Diluted Shares Outstanding | 52.93M | 50.47M | 50.40M | 50.29M | 51.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |